Xingmei Liang - Concepedia

Author

Xingmei Liang

Also Known As

Xing-mei Liang, Xingmei Liang

Publications

215

Citations

H-Index

Concepts

All Affiliations

Xingmei Liang is an author at Tianjin Medical University General Hospital specializing in tumor biology, lung cancer, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	22
2	Cell Biology	1	1	22
3	Cancer Genetics	1	1	22
4	Tumor Biology	1	1	22
5	Cancer Biology	1	1	22

Xingmei Liang

Publications

215

Citations

H-Index

Page 1

	Year	Citations
Targeting the <scp>EMT</scp> transcription factor Snail overcomes resistance to osimertinib in <scp><i>EGFR</i></scp>‐mutant non‐small cell lung cancer Qiong Qin, Xiaoqing Li, Xingmei Liang, Thoracic Cancer	2021	56
<scp>CDK4/6</scp> inhibitor palbociclib overcomes acquired resistance to third‐generation <scp>EGFR</scp> inhibitor osimertinib in <scp>non‐small</scp> cell lung cancer (<scp>NSCLC</scp>) Qiong Qin, Xiaoqing Li, Xingmei Liang, Thoracic Cancer	2020	46
Rictor regulates the vasculogenic mimicry of melanoma <i>via</i> the <scp>AKT</scp>‐<scp>MMP</scp>‐2/9 pathway Xingmei Liang, Ran Sun, Xiulan Zhao, Journal of Cellular and Molecular Medicine	2017	44
Glutamine-β-cyclodextrin for targeted doxorubicin delivery to triple-negative breast cancer tumors <i>via</i> the transporter ASCT2 Ping Zhou, Xingmei Liang, Ce Zhou, Journal of Materials Chemistry B	2019	32
Targeting DNA-PK overcomes acquired resistance to third-generation EGFR-TKI osimertinib in non-small-cell lung cancer Xingmei Liang, Qiong Qin, Boning Liu, Acta Pharmacologica Sinica Non-small-cell Lung CancerDna-pk OvercomesMedicineThird-generation Egfr-tki OsimertinibBronchial Neoplasm	2021	22
High kinesin family member 18A expression correlates with poor prognosis in primary lung adenocarcinoma Xiaoqing Li, Meirong Liu, Zheng Zhang, Thoracic Cancer	2019	15

Page 1